BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1156039)

  • 1. Comparison between the effects of ST 600 and catapres.
    Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):347-50. PubMed ID: 1156039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the effects of ST 600 and clonidine.
    Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):162-9. PubMed ID: 1190909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic and endocrine changes during anti-hypertensive treatment with clonidine and its derivative St 600.
    Kho TL; Zaal GA; Wester A; de Leeuw PW; Birkenhäger WH
    Clin Sci Mol Med Suppl; 1976 Dec; 3():641s-643s. PubMed ID: 1071697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride (Catapres) upon the systemic and coronary haemodynamics and metabolism of intact dogs.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):7-14. PubMed ID: 5350786
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new antihypertensive imidazoline derivative (St 600, Fluoronidine): I. Haemodynamic investigations at rest and during exercise (author's transl)].
    Djawan S; Mlezoch J; Niederberger M; Penner E; Grabner G
    Wien Klin Wochenschr; 1976 Mar; 88(6):199-206. PubMed ID: 973381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis.
    Cosnier D; Labrid C; Rispat G; Streichenberger G
    Arzneimittelforschung; 1975 Nov; 25(11):1802-6. PubMed ID: 1243090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation.
    Koch G
    Arzneimittelforschung; 1971 Jan; 21(1):57-61. PubMed ID: 5108382
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effects of ST 155, 2-(2,6 dichlorophenylamino)-2 imidazoline hydrochloride, in hypertensive dogs].
    Laubie M; Schmitt H
    Arch Int Pharmacodyn Ther; 1969 May; 179(1):23-5. PubMed ID: 5348396
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
    Ando K; Noda H; Ogata E; Fujita T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic and endocrinological profile of essential hypertension.
    de Leeuw PW; Kho TL; Falke HE; Birkenhäger WH; Wester A
    Acta Med Scand Suppl; 1978; 622():5-86. PubMed ID: 282795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155).
    Onesti G; Schwartz AB; Kim KE; Swartz C; Brest AN
    Circulation; 1969 Feb; 39(2):219-28. PubMed ID: 4884576
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension.
    London GM; Safar ME; Weiss YA; Corvol PL; Menard JE; Simon AC; Milliez PL
    Arch Intern Med; 1977 Aug; 137(8):1042-7. PubMed ID: 327963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine and guanfacine--comparison of their effects on haemodynamics in hypertension.
    Seedat YK
    S Afr Med J; 1985 Apr; 67(14):557-9. PubMed ID: 3887593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamics, renal function, plasma renin, and aldosterone in man after 5 to 14 days of bedrest.
    Melada GA; Goldman RH; Luetscher JA; Zager PG
    Aviat Space Environ Med; 1975 Aug; 46(8):1049-55. PubMed ID: 1100038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
    Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The behavior of hemodynamic values in hypertensive patients under treatment with dichlorophenylaminoimidazoline hydrochloride].
    Pozenel H
    Wien Klin Wochenschr; 1969 Mar; 81(10):187-92. PubMed ID: 4891025
    [No Abstract]   [Full Text] [Related]  

  • 19. The sympathetic nervous system in hypertension due to unilateral renal artery stenosis in man.
    Kooner JS; Peart WS; Mathias CJ
    Clin Auton Res; 1991 Sep; 1(3):195-204. PubMed ID: 1822252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties.
    Muir AL; Burton JL; Lawrie DM
    Lancet; 1969 Jul; 2(7613):181-4. PubMed ID: 4183136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.